09/02/2026
A new class of orexin-based drugs could transform treatment for excessive daytime sleepiness and, similarly to GLP-1s, become a blockbuster if they are indicated to address other health conditions.
morganstanley.com
Financial Advisors at Morgan Stanley
36 East Streetsboro St
Hudson, OH 44236 MSSB is not responsible for content posted by third-parties.
Hudson, OH
44236
Be the first to know and let us send you an email when The Smith Group at Morgan Stanley posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to The Smith Group at Morgan Stanley: